title: HLA class II molecule signal transduction leads to either apoptosis or activation via two different pathways.
abstract: The class II human leukocyte antigens (HLA class II) are constitutively expressed on antigen presenting cells (APC) and are essential for peptide presentation to helper T lymphocytes. Signal transduction by HLA class II molecules on B lymphocytes has been described and has been shown in many cases to induce cellular proliferation. However, since signalling via HLA class II can also lead to apoptosis, it has not been clear how the outcome of the signals is determined. We have distinguished two separate HLA class II-initiated pathways leading to either proliferation or apoptosis of primary human B lymphocytes. Proliferation requires new gene transcription and activation of src family tyrosine kinases. In contrast, apoptosis is significantly increased in the absence of transcription/translation. It is dependent on serine/threonine phosphatases and cytoskeletal mobility. An extracellular source of calcium was essential for apoptosis, suggesting the need for sustained high level of intracellular calcium. Activation of iso-enzymes of the protein kinase C family was needed for both pathways. We therefore conclude that HLA class II molecules can initiate two distinct signalling pathways leading to either proliferation or apoptosis of APC.
authors.affiliation: INSERM U396, Immunogénétique Moléculaire, Institut Biomédical des Cordeliers, Paris, France.
authors.forename: J P
authors.initials: JP
authors.lastname: Truman
authors.forename: C
authors.initials: C
authors.lastname: Choqueux
authors.forename: D
authors.initials: D
authors.lastname: Charron
authors.forename: N
authors.initials: N
authors.lastname: Mooney
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000276:immunology*; D001402:B-Lymphocytes / Q000201:enzymology / Q000276:immunology; D002118:Calcium / Q000502:physiology; D002453:Cell Cycle / Q000276:immunology; D003599:Cytoskeleton / Q000276:immunology; D006681:HLA-D Antigens / Q000494:pharmacology*; D006801:Humans; D007399:Interphase / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D011493:Protein Kinase C / Q000502:physiology; D017027:Protein Tyrosine Phosphatases / Q000502:physiology; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D013154:Spleen; D014158:Transcription, Genetic / Q000187:drug effects / Q000276:immunology
chemical_list: D006681:HLA-D Antigens; D011505:Protein-Tyrosine Kinases; D011493:Protein Kinase C; D017027:Protein Tyrosine Phosphatases; D002118:Calcium